Plasma des-acyl ghrelin, but not plasma HMW adiponectin, is a useful cardiometabolic marker for predicting atherosclerosis in elderly hypertensive patients

Atherosclerosis

Volumn 204, Issue 2, 2009, Pages 590-594

  Yano, Yuichiro ^a,b   Toshinai, Koji ^c   Inokuchi, Takashi ^d   Kangawa, Kenji ^e   Shimada, Kazuyuki ^b   Kario, Kazuomi ^b   Nakazato, Masamitsu ^c  

^a Nango National Health Insurance Hospital   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

^d Kitaura National Health Insurance Hospital   (Japan)

^e NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Atherosclerosis; Des acyl ghrelin; Elderly; HMW adiponectin; Obesity

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; GHRELIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ABDOMINAL OBESITY; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HEMOSTASIS; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SMOKING; VASCULAR PATENCY;

ADIPONECTIN; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; GHRELIN; HUMANS; HYPERTENSION; INFLAMMATION MEDIATORS; INSULIN; LIPIDS; MALE; MIDDLE AGED; MOLECULAR WEIGHT; NITRATES; NITRITES; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 67349142916     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.10.013     Document Type: Article

References (20)

1. Heiat A., Vaccarino V., and Krumholz H.M. An evidence-based assessment of federal guidelines for overweight and obesity as they apply to elderly persons. Arch Intern Med 161 (2001) 1194-1203
2. Trujillo M.E., and Scherer P.E. Adipose tissue-derived factors: impact on health and disease. Endocrinol Rev 27 (2006) 762-778
3. Matsuzawa Y., Funahashi T., Kihara S., and Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 24 (2004) 29-33
4. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1737
5. Wannamethee S.G., Whincup P.H., Lennon L., and Sattar N. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med 167 (2007) 1510-1517
6. Kadowaki T., Yamauchi T., and Kubota N. The physiological and pathophysiological role of adiponectin and adiponectin receptors in the peripheral tissues and CNS. FEBS Lett 582 (2008) 74-80
7. Kubota N., Yano W., Kubota T., et al. Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab 6 (2007) 55-68
8. Wedick N.M., Barrett-Connor E., Knoke J.D., and Wingard D.L. The relationship between weight loss and all-cause mortality in older men and women with and without diabetes mellitus: the Rancho Bernardo study. J Am Geriatr Soc 50 (2002) 1810-1815
9. Pajvani U.B., Du X., Combs T.P., et al. Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity. J Biol Chem 278 (2003) 9073-9085
10. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., and Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (1999) 656-660
11. Nakazato M., Murakami N., Date Y., et al. A role for ghrelin in the central regulation of feeding. Nature 409 (2001) 194-198
12. Kleinz M.J., Maguire J.J., Skepper J.N., and Davenport A.P. Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man. Cardiovasc Res 69 (2006) 227-235
13. Tesauro M., Schinzari F., Iantorno M., et al. Ghrelin improves endothelial function in patients with metabolic syndrome. Circulation 112 (2005) 2986-2992
14. Baldanzi G., Filigheddu N., Cutrupi S., et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol 159 (2003) 1029-1037
15. Akamizu T., Shinomiya T., Irako T., et al. Separate measurement of plasma levels of acylated and desacyl ghrelin in healthy subjects using a new direct ELISA assay. J Clin Endocrinol Metab 90 (2005) 6-9
16. Otsuki M., Hashimoto K., Morimoto Y., Kishimoto T., and Kasayama S. Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients. Diabetes 46 (1997) 2096-2101
17. The committee to evaluate diagnostic standards for metabolic syndrome 2005 Definition and the diagnostic standard for metabolic syndrome. Nippon Naika Gakkai Zasshi 94 (2005) 794-809 [in Japanese]
18. Inelmen E.M., Sergi G., Coin A., Miotto F., Peruzza S., and Enzi G. Can obesity be a risk factor in elderly people?. Obes Rev 4 (2003) 147-155
19. Barazzoni R., Zanetti M., Ferreira C., et al. Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome. J Clin Endocrinol Metab 92 (2007) 3935-3940
20. Kotani K., Sakane N., Saiga K., et al. Serum ghrelin and carotid atherosclerosis in older Japanese people with metabolic syndrome. Arch Med Res 37 (2006) 903-906